COVID drug cuts risk of death or hospitalisation in high-risk adults by 79% A second drug treatment for COVID-19 has been approved by the UK medicines regulator after it was found to cut risk of hospitalisation and death in high-risk adults by 79%. by Luke Haynes Sign in to continue Sign In Email address Password Stay signed in Trouble signing in? Reset password: Click here Need help? Email us Register FREE Limited free articles a month Free email bulletins Register Now Register Now Take a 30-day trial Join MIMS now and pay nothing for the first 30 days Join GPOnline now and pay nothing for the first 30 days Sign Up Sign Up
